Streetbeat News

Partnerships

EIS

Talks of extending the truce between Israel and Hamas are underway, with international support. 58 hostages have been released, and the fate of additional American hostages in Gaza is uncertain. Elon Musk visited an Israeli kibbutz attacked by Hamas and agreed not to activate Starlink over Gaza without Israel's approval. Israeli stocks are slightly down, while the shekel is up. The iShares MSCI Israel ETF (EIS) is expected to resume trading after a four-week winning streak.

Portfolio Pulse from Piero Cingari

November 27, 2023 | 2:36 pm

AXDX

BRKR

Accelerate Diagnostics has entered into a collaboration and quality agreement with Bruker Corporation for the use of Accelerate's Arc System with Bruker's MALDI Biotyper. This partnership aims to enhance microbial identification and antibiotic susceptibility testing.

Portfolio Pulse from Bill Haddad

November 27, 2023 | 2:17 pm

ATOMUSD

The Cosmos community has forked to create AtomOne, a new hub emphasizing sovereignty, security, and decentralization. The fork, led by Cosmos co-founder Jae Kwon, comes after governance disputes and a failed proposal to reduce ATOM token inflation. AtomOne will airdrop ATOM1 tokens to those who voted against the inflation reduction and will introduce a liquid staking system with $phATOM tokens. The initiative aims to guide the Cosmos Hub towards safer decisions and foster a more diverse ecosystem.

Portfolio Pulse from Murtuza Merchant

November 27, 2023 | 2:13 pm

ANIX

Anixa Biosciences, Inc. (NASDAQ:ANIX) announced that the European Patent Office intends to grant a patent for its ovarian cancer vaccine technology, which was developed in partnership with Cleveland Clinic. The technology, which targets AMHR2-ED expressed in ovarian cancers, has already been granted a U.S. patent and is being developed with the collaboration of the National Cancer Institute's PREVENT program.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:44 pm

AGLE

Aeglea BioTherapeutics has changed its name to Spyre Therapeutics and will trade under the symbol 'SYRE' starting November 28, 2023. The company appointed Cameron Turtle as CEO and added industry veterans Jeffrey Albers and Laurie Stelzer to its Board of Directors. Spyre is expanding its leadership team to develop therapeutic combinations for IBD, with lead programs SPY001 and SPY002 entering clinical studies in 2024. The company has a financial runway into 2026 with $205 million in cash and equivalents as of September 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:42 pm

IMAX

PATHE CINEMAS and IMAX Corporation have expanded their partnership with an agreement for five new IMAX with Laser systems in Europe, primarily France, and a three-picture slate agreement with PATHE LIVE for distribution across the IMAX network. The deal includes the release of a Filmed for IMAX ballet, 'Swan Lake', by Paris Opera and PATHE LIVE. IMAX continues to perform well in France, matching its highest grossing year at the French box office since 2019. The partnership between PATHE CINEMAS and IMAX dates back to 2010, with 26 locations across Europe and Morocco.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:41 pm

CYRX

Cryoport Inc. (NASDAQ:CYRX) and NIPPON EXPRESS HOLDINGS have formed a strategic partnership to provide global temperature-controlled supply chain services for the life sciences industry. The partnership combines Cryoport's integrated system, including shipping packages and bioservices, with Nippon Express' global logistics network. This collaboration aims to enhance Cryoport's logistics solutions and capabilities to support the life sciences and biopharmaceutical industries.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:40 pm

DRIO

DarioHealth Corp. (NASDAQ:DRIO) has secured a contract to provide its cardiometabolic solution to a national financial and business services company starting January 2024. The solution includes support for diabetes, pre-diabetes, weight management, hypertension, and GLP-1 medication users. Dario's approach combines technology and human support, aiming to improve clinical outcomes through sustained behavior change.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:38 pm

PGY

Pagaya Technologies LTD. (NASDAQ:PGY) has closed its fourth auto asset-backed securitization (ABS) deal of 2023, named RPM 2023-4, bringing its total auto issuance to $1.4 billion and overall ABS transactions to $6.3 billion for the year. The deal, rated by Kroll Bond Rating Agency, includes loans from a top 4 US auto captive and reflects Pagaya's growing network and investor demand. Pagaya's AI-driven financial products have attracted over $18 billion in ABS transactions since 2018, with a network of 90+ institutional investors.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:38 pm

HTCR

HeartCore Enterprises, Inc.'s subsidiary Sigmaways has launched Psyche60s, a virtual reality experience aimed at combining entertainment with education. The project utilizes advanced technologies like Unity, Unreal Engine, Adobe Generative AI, Nvidia computing, and ChatGPT. HeartCore's CEO highlighted Sigmaways' role in the company's growth strategy and its potential for strategic partnerships in the education sector. Psyche60s is available on Oculus, SideQuest, Steam, Google Play, and the App Store.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:34 pm